ÂÜÀòÂÒÂ×

Alan Rudolph is an accomplished leader in the fields of science, technology, and research, currently serving as Interim Chief Technology Officer at Innosphere Ventures since January 2024 and Interim Chief Executive Officer at PhotonPharma since April 2018. With extensive experience on various boards, including roles as a member of the Board of Directors for PhotonPharma and as an Executive Board Member of the Colorado BioScience Association, Rudolph also holds significant positions within nonprofit organizations, such as Director of the International Neuroscience Network Foundation. Previous roles include Vice President of Research at Colorado State University, Director of Biological and Chemical Defense at the U.S. Department of Homeland Security, and Director of the Chemical and Biological Defense program at the Pentagon. An entrepreneur, Rudolph founded Cellphire Inc., where leadership spanned from CEO to Chairman of the Board. Rudolph holds an MBA from The George Washington University and a PhD in Zoology from the University of California, Davis.